Lantern Pharma Inc.
LTRN
$1.79
$0.021.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -112.43% | 18.29% | 2.47% | 3.55% | 4.54% |
| Total Depreciation and Amortization | -0.88% | -52.02% | -13.26% | 1,106.67% | -2.17% |
| Total Amortization of Deferred Charges | -100.00% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,428.02% | -33.05% | 89.38% | 2,710.81% | -91.54% |
| Change in Net Operating Assets | 110.40% | -190.75% | 228.06% | -271.98% | 452.68% |
| Cash from Operations | 22.05% | -35.12% | 38.93% | -16.12% | 10.02% |
| Capital Expenditure | -- | -- | 100.00% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -83.71% | 349.41% | -128.74% | 65.01% | 10.88% |
| Cash from Investing | -83.71% | 349.41% | -128.74% | 64.99% | 10.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -31.45% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -45.82% | -- | -- |
| Foreign Exchange rate Adjustments | -103.98% | 486.67% | 1,100.00% | -101.08% | 896.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 252.00% | 112.48% | -270.38% | 836.27% | 72.10% |